Evaxion A (EVAX) EBITDA (2020 - 2026)

Evaxion A (EVAX) has 7 years of EBITDA data on file, last reported at -$3.8 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA rose 1.27% year-over-year to -$3.8 million; the trailing twelve-month figure through Mar 2026 stood at -$9.0 million (up 42.94% YoY), and the FY2025 full-year result was -$9.2 million, up 37.32% from the prior year.
• EBITDA for Q1 2026 stood at -$3.8 million, up from -$4.1 million in the prior quarter.
• Across five years, EBITDA topped out at $3.0 million in Q3 2025 and bottomed at -$6.5 million in Q4 2022.
• The 5-year median for EBITDA is -$4.4 million (2024), against an average of -$4.5 million.
• The widest annual swing landed in 2022, when EBITDA sank 32.42%; it then surged 274.58% in 2025.
• A 5-year view of EBITDA shows it stood at -$6.5 million in 2022, then jumped by 33.12% to -$4.4 million in 2023, then grew by 7.79% to -$4.0 million in 2024, then dropped by 0.7% to -$4.1 million in 2025, then climbed by 5.75% to -$3.8 million in 2026.
• The last three EBITDA figures came in at -$3.8 million (Q1 2026), -$4.1 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.

Peer Comparison